N99-02: Melphalan and Buthionine Sulfoximine
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
- Status
- WITHDRAWN
- Phase
- PHASE2
Vinorelbine in Treating Children With Recurrent or Refractory Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Fenretinide in Treating Children With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1